{"filing":{"accession_number":"0001193125-26-283007","cik":"0001913577","ticker":"SMNRW","company_name":"Semnur Pharmaceuticals, Inc.","form":"8-K","filing_date":"2026-06-25","report_date":null,"primary_document":"smnr-20260625.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1913577/000119312526283007/smnr-20260625.htm"},"events":[{"id":13998,"run_id":12448,"accession_number":"0001193125-26-283007","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"This is a clear disclosure of shareholder voting results from Semnur Pharmaceuticals' 2026 Annual Meeting of Stockholders held on June 25, 2026. The filing reports the outcomes of four proposals: election of a Class I director (Jay Chun, M.D., Ph.D.), ratification of Pipara \u0026 Co LLP as independent auditor, approval of the 2025 Equity Incentive Plan, and approval of the 2025 Employee Stock Purchase Plan, with detailed vote tallies for each. This is a standard Item 5.07 disclosure of shareholder meeting results, which is material to investors as it confirms governance decisions and equity plan approvals.","company_name":"Semnur Pharmaceuticals, Inc.","ticker":"SMNRW","filing_date":"2026-06-25","form":"8-K","submitted_at":null,"items":[{"id":11304,"accession_number":"0001193125-26-283007","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder voting results from Semnur Pharmaceuticals' 2026 Annual Meeting of Stockholders held on June 25, 2026. The filing reports the outcomes of four proposals: election of a Class I director (Jay Chun, M.D., Ph.D.), ratification of Pipara \u0026 Co LLP as independent auditor, approval of the 2025 Equity Incentive Plan, and approval of the 2025 Employee Stock Purchase Plan, with detailed vote tallies for each. This is a standard Item 5.07 disclosure of shareholder meeting results, which is material to investors as it confirms governance decisions and equity plan approvals.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-25T21:04:37.463702+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":11304,"accession_number":"0001193125-26-283007","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder voting results from Semnur Pharmaceuticals' 2026 Annual Meeting of Stockholders held on June 25, 2026. The filing reports the outcomes of four proposals: election of a Class I director (Jay Chun, M.D., Ph.D.), ratification of Pipara \u0026 Co LLP as independent auditor, approval of the 2025 Equity Incentive Plan, and approval of the 2025 Employee Stock Purchase Plan, with detailed vote tallies for each. This is a standard Item 5.07 disclosure of shareholder meeting results, which is material to investors as it confirms governance decisions and equity plan approvals.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-25T21:04:37.463702+00:00","company_name":"Semnur Pharmaceuticals, Inc.","ticker":"SMNRW","filing_date":"2026-06-25"}]}